NIH R01 · 2024
Prospective Study of Vitamin D and MS Risk in African Americans
PROJECT SUMMARY In spite of progress in treatment and promising new drugs multiple sclerosis (MS) continues to be a chronic progressive disease with a high impact on the quality of life of those affected, their families, and society. Further, MS incidence is increasing among US Blacks and among women of all races in several regions in the world. These rapid increases cannot be explained by genetic factors, and strongly suggest that environmental factors, possibly modifiable, are contributing to determine MS risk. Vitamin D is likely to be one of these factors, but questions remain on the role of vitamin D in MS particularly among blacks. Ten years ago, we published a landmark paper…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.
← All labs at Harvard University D/B/a Harvard School of Public Health